Immunotech Biopharm Ltd (HKG:6978)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.5400
-0.0100 (-1.82%)
Jul 10, 2026, 3:30 PM HKT
Market Cap339.63M -78.4%
Revenue (ttm)n/a
Net Income-256.82M
EPS-0.47
Shares Out 617.50M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume24,000
Open0.5500
Previous Close0.5500
Day's Range0.5400 - 0.5500
52-Week Range0.5000 - 5.8300
Beta0.15
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About Immunotech Biopharm

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China. The company’s core product is EAL, a multi-target cellular immunotherapy product that has completed Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia that is in Phase II/III clinical trial; 6B... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 183
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6978
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements